GBI Research, Dec 2011, Pages: 76
, market segments and companies likely to impact the pharmaceutical packaging market in the future.
- Formulate effective sales and marketing strategies through understanding of the competitive landscape
GBI Research, Dec 2009, Pages: 62
players with a potentially strong product portfolio and create effective counter-strategies to gain a competitiveadvantage.
- Organize your sales and marketing efforts by identifying the market categories
GBI Research, Feb 2010, Pages: 89
of 34% over the same period. The market for RFID hardware is the largest at the initial stages of adoption in the pharmaceutical industry. Service providers are gaining market share by integrating
Business Insights, Jan 2011, Pages: 96
markets and gaining strength in higher margin services such as high-potency APIs and biologics will be key strategies for Chinese CMOs to overcome intense competition.The drivers of Chinese CMO
Frost & Sullivan, March 2011, Pages: 50
markets in Japan. The study ends with a competitive market analysis, which includes the top domestic companies in the Japan generics market. Additionally, it lists the top ten pharmaceutical companies
James Dudley Management, Sep 2010, Pages: 111
- GainingCompetitiveAdvantages for Generic Pharmaceutical Products in Internet Pharmacies
- Taking Mail Order and Internet Pharmacy to a New Level in Europe
Figures, Graphs and Tables
Chapter 1
Figure 1
GBI Research, May 2011, Pages: 108
Transfer as a Key Component to GainingCompetitiveAdvantage
The efficient and effective transfer of new technologies is widely recognized as being a key component of gainingcompetitiveadvantage
Digital Vector, April 2007, Pages: 325
where the top firms granted patents are mostly MNCs. Indian industry instead mastered the art of reverse engineering to gaincompetitiveadvantage, as the industry structure did not provide incentives
Business Insights, Feb 2010, Pages: 146
for manufacturing marketed drugs.
Sourcing APIs from low-cost suppliers is a key strategy for pharmaceutical companies pressured by the emerging ‘patent cliff’. The model of vertical integration that dominated
FirstWord Publishing, July 2011, Pages: 38
pharmaceuticals sold.
Yet while those issues may seem insurmountable, gaining access to the fast-growing and potentially rich Brazilian market is not impossible—with the right information.
Report Overview
Frost & Sullivan, Feb 2008, Pages: 224
This Frost & Sullivan research service titled Infectious Disease PharmaceuticalMarkets in Key Sub-Saharan African Countries provides market sizes and growth forecasts for the period 2006 to 2012
Frost & Sullivan, March 2011, Pages: 48
and generics markets in Australia. The report ends with a competitive market analysis, which includes the top domestic companies in the Australia generics market.
Research Overview
This Frost & Sullivan
Decision Resources, Inc., July 2008, Pages: 43
to China 15
CompetitiveAdvantage Through Size and Scale of Operations 16
Modernizing Traditional Chinese Medicines 19
Moving Up the Pharmaceutical Value Stream 20
Access to Money and Capital Markets 21
U
Biopharm Knowledge Publishing, Sep 2008, Pages: 100
trade-off
3.3.6 Working with CROs in emerging markets
4.0 Virtual Manufacturing
4.1 Advantages of a virtual drug manufacturing model
4.1.1 Gain access to capacity with low upfront investment
4
GlobalData, Oct 2011, Pages: 17
a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gaincompetitiveadvantage.
- Develop competition strategies by identifying
HBS Consulting, Feb 2006
without as you develop your own DTCM strategy without the cost by utilizing the foundations from our "Manual" "Direct-to-Consumer Marketing of Prescription Pharmaceuticals in Europe" was designed to help
Eularis, June 2011, Pages: 84
and advice. Overview and Background to the Report: Increasing Cost and Effort of Marketing Medicines: It is estimated that in the US, the pharmaceutical industry spends about $15 Billion a year promoting
Decision Resources, Inc., Dec 2007, Pages: 39
options are essential to achieve success in today’s evolving markets? What are the future implications of these changes for pharmaceutical companies?
- Pharmaceutical companies must ensure they are “fit
Business Insights, May 2006, Pages: 199
The expansion of the EU has created exciting opportunities for pharmaceutical companies to expand into new territories and take advantage of these high growth emerging markets; this report analyzes
Global Industry Analysts, Inc., Sep 2011, Pages: 577
is a result of two main factors – lack of FDA regulations for Internet pharmaceutical promotion, and lack of corporate support. However, this outlet is gaining considerable attention and investments are rapidly
